Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

@article{Loblaw2007InitialHM,
  title={Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.},
  author={D. Andrew Loblaw and Katherine S. Virgo and Robert Nam and Mark R. Somerfield and Edgar Ben-Josef and David S. Mendelson and Richard Middleton and Stewart A Sharp and Thomas James Smith and James Austin Talcott and Maryellen Taplin and Nicholas John Vogelzang and James Lloyd Wade and Charles L Bennett and Howard I. Scher},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2007},
  volume={25 12},
  pages={1596-605}
}
PURPOSE To update the 2004 American Society of Clinical Oncology (ASCO) guideline on initial hormonal management of androgen-sensitive, metastatic, recurrent, or progressive prostate cancer (PCa). METHODS The writing committee based its recommendations on an updated systematic literature review. Recommendations were approved by the Expert Panel, the ASCO Health Services Committee, and the ASCO Board of Directors. RESULTS Seven randomized controlled trials (four new), one systematic review… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 194 extracted citations

Similar Papers

Loading similar papers…